173 related articles for article (PubMed ID: 22095049)
1. [Treatment of pulmonary fibrosis. New substances and new interventions].
Costabel U; Bonella F
Internist (Berl); 2011 Dec; 52(12):1422-8. PubMed ID: 22095049
[TBL] [Abstract][Full Text] [Related]
2. High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Demedts M; Behr J; Buhl R; Costabel U; Dekhuijzen R; Jansen HM; MacNee W; Thomeer M; Wallaert B; Laurent F; Nicholson AG; Verbeken EK; Verschakelen J; Flower CD; Capron F; Petruzzelli S; De Vuyst P; van den Bosch JM; Rodriguez-Becerra E; Corvasce G; Lankhorst I; Sardina M; Montanari M;
N Engl J Med; 2005 Nov; 353(21):2229-42. PubMed ID: 16306520
[TBL] [Abstract][Full Text] [Related]
3. Non-steroid agents for idiopathic pulmonary fibrosis.
Spagnolo P; Del Giovane C; Luppi F; Cerri S; Balduzzi S; Walters EH; D'Amico R; Richeldi L
Cochrane Database Syst Rev; 2010 Sep; (9):CD003134. PubMed ID: 20824834
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant therapy for idiopathic pulmonary fibrosis.
Hunninghake GW
N Engl J Med; 2005 Nov; 353(21):2285-7. PubMed ID: 16306527
[No Abstract] [Full Text] [Related]
5. Pirfenidone. First, do no harm.
Prescrire Int; 2013 May; 22(138):117-9. PubMed ID: 23819168
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic pulmonary fibrosis: current and future treatment options.
Davies HR; Richeldi L
Am J Respir Med; 2002; 1(3):211-24. PubMed ID: 14720059
[TBL] [Abstract][Full Text] [Related]
7. Treatment of idiopathic pulmonary fibrosis: is there anything new?
Abdelaziz MM; Samman YS; Wali SO; Hamad MM
Respirology; 2005 Jun; 10(3):284-9. PubMed ID: 15955138
[TBL] [Abstract][Full Text] [Related]
8. Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.
Rochwerg B; Neupane B; Zhang Y; Garcia CC; Raghu G; Richeldi L; Brozek J; Beyene J; Schünemann H
BMC Med; 2016 Feb; 14():18. PubMed ID: 26843176
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary fibrosis--a therapeutic dilemma?].
Günther A; Markart P; Eickelberg O; Seeger W
Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Walter N; Collard HR; King TE
Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
[TBL] [Abstract][Full Text] [Related]
11. [Drug treatments for idiopathic pulmonary fibrosis].
Crestani B; Marchand-Adam S; Schneider S
Rev Pneumol Clin; 2005 Jun; 61(3):221-31. PubMed ID: 16142196
[TBL] [Abstract][Full Text] [Related]
12. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.
Covvey JR; Mancl EE
Ann Pharmacother; 2014 Dec; 48(12):1611-9. PubMed ID: 25202034
[TBL] [Abstract][Full Text] [Related]
13. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
; Raghu G; Anstrom KJ; King TE; Lasky JA; Martinez FJ
N Engl J Med; 2012 May; 366(21):1968-77. PubMed ID: 22607134
[TBL] [Abstract][Full Text] [Related]
14. [Expectation of new treatments for idiopathic interstitial pneumonias].
Azuma A
Nihon Ronen Igakkai Zasshi; 2005 Jan; 42(1):27-30. PubMed ID: 15732351
[TBL] [Abstract][Full Text] [Related]
15. Novelty in treatment of pulmonary fibrosis: pulmonary hypertension drugs and others.
Correale M; Totaro A; Lacedonia D; Montrone D; Di Biase M; Barbaro Foschino MP; Brunetti ND
Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):169-78. PubMed ID: 24011020
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of idiopathic pulmonary fibrosis].
Dury S
Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
[No Abstract] [Full Text] [Related]
17. Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.
Behr J; Neuser P; Prasse A; Kreuter M; Rabe K; Schade-Brittinger C; Wagner J; Günther A
BMC Pulm Med; 2017 Sep; 17(1):122. PubMed ID: 28877715
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
19. Treatment switching in idiopathic pulmonary fibrosis: from triple therapy to enrollment into a clinical investigational drug trial.
Valenzuela C; Ancochea J
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Sep; 30 Suppl 1():44-7. PubMed ID: 24081245
[TBL] [Abstract][Full Text] [Related]
20. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE; Bradford WZ; Castro-Bernardini S; Fagan EA; Glaspole I; Glassberg MK; Gorina E; Hopkins PM; Kardatzke D; Lancaster L; Lederer DJ; Nathan SD; Pereira CA; Sahn SA; Sussman R; Swigris JJ; Noble PW;
N Engl J Med; 2014 May; 370(22):2083-92. PubMed ID: 24836312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
